African American teens at greater risk of tobacco addiction

January 29, 2001

NIDA Research Finds That African American Teens Are at Greater Risk of Tobacco Addiction

For African American teens who smoke, culturally-appropriate evaluation of nicotine dependence is an important part of cessation treatment, according to a study published in the December 2000 issue of the Journal of the National Medical Association.

African American students continue to have the lowest rates of smoking among the nation's 8th, 10th, and 12th graders, according to results from the 2000 Monitoring the Future Study, an annual survey that tracks drug and alcohol use by secondary school students. However, extensive research also demonstrates the disproportionate effects of tobacco use among African Americans, who are at greater risk of developing long-term consequences, such as smoking-related coronary heart disease, stroke, and lung cancer, than are their non-African-American counterparts. The new study reinforces these findings and clarifies some of the distinguishing characteristics of tobacco addiction among adolescent African Americans.

"This study indicates that African American youth may be in danger of experiencing the negative effects of tobacco earlier in their smoking histories, and assessments and interventions need to be tailored to their specific needs," says Dr. Alan I. Leshner, director, National Institute on Drug Abuse (NIDA). "Until we are able to provide this level of service to young people of all ethnic backgrounds, we will continue to have increasing numbers of nicotine-addicted adults."

The study was led by Dr. Eric T. Moolchan, a pediatrician and researcher at NIDA's Intramural Research Program in Baltimore, Maryland. Dr. Moolchan also is the director of NIDA's Teen Tobacco Addiction Treatment Research Clinic, which was established to conduct research into adolescent nicotine addiction and to test promising therapies for helping teens to quit smoking. He and his colleagues assessed the smoking-related characteristics of African American and non-African American teenagers who applied to be participants in a smoking cessation trial. A total of 115 subjects responded by telephone to advertisements about the trial. The researchers used the Fagerstrm Test for Nicotine Dependence (FTND) as the basis for telephone interviews, and the self-reported data included sociodemographic information (such as age, sex, and ethnoracial affiliation); medical, psychiatric, and medications history; smoking history; previous cessation attempts; and motivation to quit.

The researchers found that the African American applicants tended to be significantly older and smoked less on the weekends and on average fewer cigarettes each day than their non-African American counterparts. Yet their smoking histories and motivation scores were similar, and both groups experienced asthma, allergies, and depression at similar rates.

The data support other research that indicates ethnoracial differences in the metabolism of nicotine among smoking adults. However, this is the first study to suggest similar findings in an adolescent population. According to Dr. Moolchan, "Given the potential differences in the metabolic profile of nicotine among ethnic groups, we suggest that use of an awareness-based instrument, in addition to other measures of dependence, might provide clinicians with clearer and more useful diagnoses of nicotine dependence."

The research team predicts that the currently observed tobacco-related health disparities seen in African Americans are likely to increase if proactive, culturally relevant prevention and treatment programs are not implemented.
-end-
Note to reporters: The full text of the article, "African-American Teen Smokers: Issues to Consider for Cessation Treatment," can be found in the December 2000 issue of the Journal of the National Medical Association: Vol. 92, number 12, pgs. 558-562.

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports more than 85 percent of the world's research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and other topics can be ordered free of charge in English and Spanish through NIDA Infofax at 1-888-NIH-NIDA (644-6432) or 1-888-TTY-NIDA (889-6432) for the deaf. These fact sheets and further information on NIDA research and other activities can be found on the NIDA home page at http://www.drugabuse.gov.

NIH/National Institute on Drug Abuse

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.